Cytotoxic factors to tumour cells, such as tumour necrosis factor (TNF) can be induced in sera endogenously by some conjugated polysaccharides (Carswell et al., 1975; Takahashi et al., 1985) . Induction of the cytotoxic factor (CF) is thought to be related to the antitumour activities of the polysaccharides. However, CF activity has been mainly examined in sera, but its activity in tumour tissues is likely to be more biologically relevant for antitumour mechanisms. In fact, it has been shown that TNF is effective at a lower dose when injected into tumours than when injected systemically .
Studies are in progress in our laboratory on the antitumour and immunomodulating activities of purified mannoglucans prepared from the actinomycetes Microellobosporia grisea (Inoue et al., 1983) . These mannoglucans, which have a unique, tetrasaccharide repeating-unit structure, have molecular weights of about 3-10 x 102 kD and show antitumour activity without detectable side effects (Nakajima et al., 1984) . In preceding papers, we reported that MGA, a polyalcoholized mannoglucan, caused tumour ischaemia and rapid and definite growth inhibition of the MH134 hepatoma in C3H/He mice (Abe et al., 1984 (Ruff et al., 1980) and mouse (Carswell et al., 1975) (Ruff et al., 1980) as described previously . The cytotoxic activity was calculated as mean of the ratio of the dilution of the test sample required to induce 50% killing of L-929 cells (ED50) to that of standard rabbit TNS (6 x103 Uml-1). The ED50 value of standard rabbit TNS was 105-10-55 (Abe et al., 1984 . Following MGA treatment, the blood circulation in tumour tissues is inhibited within 6 h and tumour growth retarded within 3 days (Abe et al., 1984) . Using this system, we searched for cytotoxic factors induced by MGA in tumour tissues.
Cytotoxic activity was measured in the clear supernatants obtained by centrifugation of homogenates of tumour tissues. As seen in Figure 1 , the supematants of homogenates of MH134 tumour tissues from MGA-treated mice showed dose-dependent cytotoxicity to L-929 cells, but similar preparations from untreated mice did not, indicating that MGA induced a cytotoxic factor (CF) in turnour tissues. The dose-response pattern of the CF was similar to that of rabbit tumour necrosis serum prepared by a conventional method (Ruff et al., 1980) . This similarity suggested that the CF in tumour tissues and TNF might have similar cytotoxic activity. To examine the recovery of the CF during sample preparation, a known quantity (170 units) of murine-TNF was added to the tumour tissues before their homogenization and the cytotoxic activity in the final supernatants measured. The cytotoxic activity of murine-TNF was recovered completely (data not shown).
The time course of CF induction in tumour-tissues was examined after MGA administration to the mice. CF activity in tumour tissues was detectable after 1 h, and maximal after 3 h, and decreased by 6 h after MGA administration ( Figure  2 ). Therefore in subsequent experiments, CF activity was usually measured 3 h after MGA administration. Figure 3 shows the dose-response of CF activity to MGA injected i.v. into tumour-bearing mice. The CF in tumour tissues was detectable after injection of MGA at 5 ,ug/mouse and maximal after injection of 100-2,000 yg/mouse.
Selective induction of CF in tumour tissues
Previously we reported that TNF-like CF was induced in sera . Here, we examined the tissue selectivity of CF induction in tumour-bearing mice. Table I In C: shows that CF was induced in tumour tissues. Small amounts of CF were also detectable in sera, skin and lung tissues, but not in muscle, liver or spleen tissues. Thus MGA induced CF activity in selective sites in tumour-bearing mice. For comparison with MGA, the efficacy of lipopolysaccharide (LPS), which induces TNF in sera within 2h of i.v. injection into mice primed with Bacillus Calmette-Guerin was tested. LPS induced a low level of CF in the serum, but not in tumour tissues under these conditions (Table I) .
Characterization of CF induced in tumour tissues
The CF induced in tumour tissues was partially characterized and compared with mTNF, which was induced in sera by a conventional method (Carswell et al., 1975) . Figure  4 shows the profile of the CF from tumour tissues on gel filtration (TSK-3000 SW), from which the molecular size was estimated to be 7080 kD. CF activity in murine TNF, examined as a control, was recovered in the same fractions as CF from tumour tissues ( Figure 5 ). The antigenicity of the CF was examined with anti-mTNF serum. Table II shows that the CF activity was inhibited by anti-mTNF serum. Therefore, this CF was characterized as a TNF-like cytotoxic factor. Figure 1 ).
(ii) The molecular sizes of the CF and murine TNF were both estimated to be 70-80 kD (Figure 4 ).
(iii) The activity of the CF was inhibited by anti-mTNF serum (Table II) . The mol. wt of murine TNF has been estimated by gel filtration to be -40kD (Haranaka et al., 1986) and -70-80kD (Beutler et al., 1985; Kull et al., 1984) ; our results are concordant with the latter. The different estimates of the molecular size of murine TNF may be attributable to differences in the conditions of gel filtration. In the present experiments, gel filtration was performed using the same type of HPLC column and buffer as those of Kull et al. (1984) . LPS is known to induce TNF in sera (Carswell et al., 1975; Takahashi et al., 1985) . Actually, we found that it induced a low level of serum TNF activity (Table I) . By contrast, MGA induced TNF-like CF selectivity in particular sites. After i.v. administration of MGA, the CF of tumour tissues reached a maximum, 24Ug-1 of tumour (wet wt) in 3h whereas the CF activities of the skin, lung, liver, spleen and muscle tissues and sera, were low or negligible. This selective induction of the CF in tumour tissues is a characteristic of MGA.
The mechanism of this selective effect of MGA is now being examined. There are several types of inflammatory host cells (e.g., polymorphonuclear leukocytes, macrophages) in solid tumours and their functional status in tumour tissues and other anatomical regions may be different (reviewed by Evans, 1982) . It is therefore not surprising that the CF was induced selectively in tumours. The selective induction of the CF could be caused by natural inflammatory actions at the site of growing tumours. This speculation is supported by our preliminary finding (unpublished data) that following i.d. injection of non-tumorous inflammatory agents, systemic administration of MGA induced the CF preferentially in skin tissues.
The in vivo significance of the local induction of cytotoxic factors by MGA should be clarified. MGA treatment increased the level of cytotoxic factor in tumours to-20-30 U g-1. We have reported that when injected intratumorally, a small dose (60 units/mouse) of partially purified rabbit TNF was effective in inhibiting the growth of MH134 hepatoma . So, 20-30Ug-1 CF in tumours would be expected to have some inhibitory effect.
MGA caused infiltration of polymorphonuclear leukocytes into tumours and inhibited the blood flow in capillaries in the tissue within 6h of administration, with arrest of tumour growth . Similar phenomena were reported as responses of tumours to injection of exogenous TNF (Balkwill et al., 1986) . So, it is hypothesized that a part of the antitumour activity of MGA is the induction of CF in tumours as well as the other immunopharmacological effects of MGA (Nakajima et al., 1984b) such as augmentation of the cytotoxic activity of macrophages, NK cells and killer cells and the induction of interleukin I and colony stimulating factors.
The in situ induction of a TNF-like cytotoxic factor in tumours by MGA provides a novel approach to tumour treatment with a potential for improved therapeutic efficacy and minimal systemic toxicity (Oshima et al., 1986) .
